<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001513'>Obesity</z:hpo> has been associated with increased incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Adipose tissue dysfunction accompanied with alterations in the release of adipocytokines has been proposed to contribute to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> pathogenesis and progression </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to analyze plasma concentrations of several adipose tissue expressed hormones in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and morbidly <z:mp ids='MP_0001261'>obese</z:mp> (MO) patients and to compare these concentrations to clinicopathological parameters </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Plasma concentrations of adiponectin, resistin, leptin, active plasminogen activator inhibitor (PAI)-1, monocyte chemotactic protein (<z:chebi fb="17" ids="50099">MCP</z:chebi>)-1, interleukin (IL)-1 alpha, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha were determined in 67 patients operated on for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (31 rectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, 36 <z:hpo ids='HP_0003003'>colon cancers</z:hpo>), 37 patients operated on for morbid <z:hpo ids='HP_0001513'>obesity</z:hpo> and 60 healthy blood donors (BD) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Compared to BD, leptin concentrations were lowered in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients whereas those of MO patients were elevated </plain></SENT>
<SENT sid="5" pm="."><plain>Adiponectin concentrations were only lowered in MO patients </plain></SENT>
<SENT sid="6" pm="."><plain>Concentrations of <z:chebi fb="17" ids="50099">MCP</z:chebi>-1, PAI-1, and IL-1 alpha were elevated in both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and MO patients, while resistin and TNF-alpha were similarly expressed in MO and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients compared to BD </plain></SENT>
<SENT sid="7" pm="."><plain>Resistin concentrations positively correlated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> staging (p&lt;0.002) and grading (p=0.015) of <z:e sem="disease" ids="C1527408,C0034885" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">rectal tumor</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The results suggest that both MO and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> have low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> as part of their etiology </plain></SENT>
</text></document>